Core Insights - The meeting between Jiangsu Province Governor Liu Xiaotao and Roche Group's global executive committee member Hornsch highlighted the potential for collaboration in the biopharmaceutical sector, which is a strategic emerging industry for Jiangsu [1] - Liu emphasized the importance of Roche's innovative research capabilities and encouraged the company to deepen its investment and innovation efforts in Jiangsu, aligning with China's health-first development strategy [1] - Hornsch expressed gratitude for the support from Jiangsu and reaffirmed Roche's commitment to local innovation and providing high-quality healthcare products and services in China [1] Group 1 - Jiangsu is focusing on biopharmaceuticals as a key strategic emerging industry [1] - Roche Group is recognized for its strong innovative research capabilities, indicating a broad space for collaboration [1] - The meeting aligns with the implementation of China's health-first development strategy, aiming to enhance public health and quality of life [1] Group 2 - Roche's largest single investment project in China is progressing well, reflecting the company's confidence in the Chinese market [1] - The company aims to deepen localized innovation cooperation to achieve high-level mutual benefits [1] - Jiangsu Province plans to build a comprehensive service chain for enterprises, enhancing intellectual property protection to maximize innovation potential [1]